BioCentury
ARTICLE | Clinical News

Lidakol 10 percent n-docosanol data

April 15, 2013 7:00 AM UTC

LDAKA released additional results from a trial in 10 HIV-1 infected patients with KS (see BioCentury March 24, 1997). All 10 patients exhibited decreased lesion size after 3 months, and of 2 biopsies performed 1 showed absence of KS and the other showed disease regression. None of the patients showed signs of systemic spread of the disease, and all 10 elected to continue treatment. ...